Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$11.63 - $21.55 $831,219 - $1.54 Million
71,472 Added 135.6%
124,181 $1.9 Million
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $104,220 - $173,783
-6,267 Reduced 10.63%
52,709 $1.07 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $566,455 - $935,335
-27,365 Reduced 31.69%
58,976 $1.72 Million
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $339,871 - $505,257
17,841 Added 26.05%
86,341 $1.86 Million
Q2 2021

Aug 16, 2021

BUY
$18.93 - $25.65 $279,425 - $378,619
14,761 Added 27.47%
68,500 $1.76 Million
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $408,446 - $749,737
34,439 Added 178.44%
53,739 $980,000
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $139,925 - $226,968
19,300 New
19,300 $223,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.